News of Note—Recro and Novartis extend pact

Woman typing on computer
Pacira Pharmaceuticals says that CMDO Thermo Fisher Scientific Pharma Services has started commercial production of its a surgical pain drug Exparel. (Max Pixel CC0)

> Recro Pharma has entered into a five-year manufacturing and supply agreement with Novartis to continue to be the exclusive global supplier of Ritalin LA and Focalin XR capsules through 2023. Release

> Pacira Pharmaceuticals says that CMDO Thermo Fisher Scientific Pharma Services has started commercial production of its a surgical pain drug Exparel at a facility in the U.K. that is expected to double the company’s manufacturing capacity. Release

> Women’s health focused Mithra says it has successfully produced its first commercial batch of vaginal contraceptive Myring for the European market. Release (PDF)